Comparison of Loteprednol 0.5% with Fluorometholone 0.1% after Myopic Photorefractive Keratectomy (PRK)

Vice Chancellor Of Research, Shahid Beheshti University of Medical Sciences0 个研究点目标入组 62 人开始时间: 待定最近更新: 2018年2月22日

适应症

试验速览

暂无简介。

•age more than 18 years;
•stable refraction for at least 12 month with myopia between -8.0 to -1.0 Diopters and astigmatism less than 4.0 Diopters;
•normal eye examination (except refractive error);
•corrected distance visual acuity (CDVA) of 20/20;
•no history of systemic or autoimmune disease or receiving immunosuppressive treatment;
•neither pregnant nor breast feeder;
•using no topical ophthalmic medication;
•have no contraindication for PRK.
•Exclusion criteria:
•Patients were unable to return for follow-up or needed to increase drug dosage for any reason;
•patients who did not follow the instructions correctly;
•patients with anisometropia (more than 1 diopter) or significant pre-operative central corneal thickness difference between two eyes (more than 20 µm); those who received MMC just in one eye;
•patients with postoperative complications like keratitis.

发起方

Vice Chancellor Of Research, Shahid Beheshti University of Medical Sciences